Purpose

The Center of Prevention & Evaluation (COPE) is a clinical research program for young people (ages 12-30) who are at elevated risk for psychosis, as compared with peers. Increased risk may be related to genetic risk (having an ill family member) and/or having symptoms, such as changes in perception, unusual thoughts, odd behavior, and social withdrawal. Other symptoms may include: loss of interest or lack of motivation, trouble thinking clearly, changes in sleeping or eating patterns, less concern with appearance or clothes, feeling suspicious of others, or feeling like things are unreal.

Type of Study: Observational Type
Setting of Study: outpatient
Clinical Trials.gov number: 
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes
Care is provided in languages: English

Study Activities

Filling Out Forms
Computer Tasks
MRI Scan
Psychophysiology measurements
Provides Payment: Reimbursement for transportation
Provides Payment: Compensation for study related procedures

Eligibility

Ages Eligible for Study: 12 Years - 30 Years
Genders Eligible for Study: Both
This study is recruiting Healthy Volunteers.

Criteria

Location: NYSPI Unit 55 1051 Riverside Drive, Suite 4800 New York, NY 10032
Clinic: Prodromal Clinic
Division: Other

Study chairs or principal investigators:
Cheryl Corcoran MD, Principal Investigator

Co-investigators:
Scott Schobel,